Morgan Stanley’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$11.3M	Sell	684,063 -121,467	-15%	-$2.32M	﹤0.01%	3474
2025 Q4	$12.6M	Buy	805,530 +160,334	+25%	+$2.16M	﹤0.01%	3388
2025 Q3	$4.78M	Buy	645,196 +74,746	+13%	+$396K	﹤0.01%	4193
2025 Q2	$2.57M	Buy	570,450 +148,360	+35%	+$662K	﹤0.01%	4548
2025 Q1	$1.96M	Sell	422,090 -1,833,263	-81%	-$11.2M	﹤0.01%	4613
2024 Q4	$15.7M	Buy	2,255,353 +2,130,021	+1,700%	+$16M	﹤0.01%	2996
2024 Q3	$664K	Buy	125,332 +56,990	+83%	+$288K	﹤0.01%	5263
2024 Q2	$256K	Buy	68,342 +12,612	+23%	+$64.3K	﹤0.01%	5570
2024 Q1	$393K	Sell	55,730 -107,222	-66%	-$636K	﹤0.01%	5418
2023 Q4	$921K	Buy	162,952 +126,886	+352%	+$498K	﹤0.01%	5329
2023 Q3	$173K	Sell	36,066 -15,014	-29%	-$96.7K	﹤0.01%	5648
2023 Q2	$350K	Buy	51,080 +12,850	+34%	+$83.1K	﹤0.01%	5395
2023 Q1	$298K	Sell	38,230 -69,467	-65%	-$483K	﹤0.01%	5518
2022 Q4	$820K	Sell	107,697 -14,426	-12%	-$120K	﹤0.01%	4972
2022 Q3	$996K	Sell	122,123 -17,526	-13%	-$161K	﹤0.01%	4882
2022 Q2	$1.35M	Buy	139,649 +4,970	+4%	+$49.9K	﹤0.01%	4817
2022 Q1	$1.89M	Sell	134,679 -1,260	-0.9%	-$17.5K	﹤0.01%	4555
2021 Q4	$2.77M	Buy	135,939 +42,038	+45%	+$880K	﹤0.01%	4302
2021 Q3	$2.09M	Buy	+93,901	New	+$2.69M	﹤0.01%	4531